I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Scarfò, L.
763
results:
Search for persons
X
Format
Online (763)
Mediatypes
Articles (Online) (278)
Bookchapter (Online) (12)
OpenAccess-fulltext (473)
Languages
english (629)
more...
italian (14)
spanish (45)
french (7)
portuguese (2)
less...
Sorted by: Relevance
Sorted by: Year
?
1
EE82 A Cost-Utility Analysis of the MyPal eHealth Applicati..:
Naoum, P.
;
Athanasakis, K.
;
Radova, L.
...
Value in Health. 26 (2023) 12 - p. S66 , 2023
Link:
https://doi.org/10.1016/..
?
2
EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PH..:
Frustaci, A. M.
;
Montillo, M.
;
Rossi, D.
...
Hematological Oncology. 41 (2023) S2 - p. 62-63 , 2023
Link:
https://doi.org/10.1002/..
?
3
PB2362: BEST PRACTICES ON EMPOWERING AND INVOLVING PATIENTS..:
Vrontaras, N.
;
Kyrou, D.
;
Kapetanakis, A.
...
HemaSphere. 6 (2022) - p. 2231-2232 , 2022
Link:
https://doi.org/10.1097/..
?
4
PB2349: LESSONS LEARNED FROM THE MYPAL DIGITAL HEALTH INTER..:
Karamanidou, C.
;
Scarfò, L.
;
Doubek, M.
...
HemaSphere. 6 (2022) - p. 2218-2219 , 2022
Link:
https://doi.org/10.1097/..
?
5
P593: MULTIDIMENSIONAL ANALYSIS OF THE B CELL RECEPTOR OFFE..:
Agathangelidis, A.
;
Galigalidou, C.
;
Iatrou, A.
...
HemaSphere. 6 (2022) - p. 492-493 , 2022
Link:
https://doi.org/10.1097/..
?
6
S144: IMMUNE RESTORATION AND SYNERGISTIC ACTIVITY WITH FIRS..:
Solman, I.
;
Singh Mali, R.
;
Scarfo, L.
...
HemaSphere. 6 (2022) - p. 45-46 , 2022
Link:
https://doi.org/10.1097/..
?
7
P597: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY IN ..:
Bordini, J.
;
Lenzi, C.
;
Toscani, L.
...
HemaSphere. 6 (2022) - p. 496-497 , 2022
Link:
https://doi.org/10.1097/..
?
8
IBRUTINIB TOLERABILITY AND OUTCOME IN PATIENTS WITH HIGH‐RI..:
Condoluci, A.
;
Terzi‐di‐Bergamo, L.
;
Forestieri, G.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
9
ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS ..:
Terzi di Bergamo, L
;
Forestieri, G
;
Loh, J. W
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
10
EFFICACY AND DISCONTINUATION RATE OF IBRUTINIB IN TREATMENT..:
Visentin, A.
;
Mauro, F. R.
;
Cibien, F.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
11
MOLTO, A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CL..:
Frustaci, A. M.
;
Tedeschi, A.
;
Zinzani, P. L.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
12
Refractory and 17p-deleted chronic lymphocytic leukemia: im..:
Farina, L.
;
Barretta, F.
;
Scarfò, L.
...
Biology of Blood and Marrow Transplantation. 26 (2020) 10 - p. e256-e262 , 2020
Link:
https://doi.org/10.1016/..
?
13
UMBRALISIB MONOTHERAPY DEMONSTRATES EFFICACY AND SAFETY IN ..:
Zinzani, P.
;
Samaniego, F.
;
Jurczak, W.
...
Hematological Oncology. 37 (2019) S2 - p. 182-183 , 2019
Link:
https://doi.org/10.1002/..
?
14
SAFETY AND CLINICAL ACTIVITY OF RP6530, A DUAL PI3Kδ/γ INHI..:
Carlo‐Stella, C.
;
Barde, P.
;
Delarue, R.
...
Hematological Oncology. 35 (2017) S2 - p. 263-263 , 2017
Link:
https://doi.org/10.1002/..
?
15
A MRD‐GUIDED APPROACH FOR THE COMBINATION OF IBRUTINIB TO V..:
Ghia, P.
;
Scarfò, L.
;
Coscia, M.
...
Hematological Oncology. 35 (2017) S2 - p. 426-427 , 2017
Link:
https://doi.org/10.1002/..
1-15